Bioptik Technology Incorporation (TPEX:4161)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
25.05
-0.35 (-1.38%)
At close: Mar 27, 2026

TPEX:4161 Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
837.19865.34828.5767.75737.89
Revenue Growth (YoY)
-3.25%4.45%7.91%4.05%51.95%
Cost of Revenue
593.68597.43588.96590.29574.35
Gross Profit
243.51267.91239.54177.46163.55
Selling, General & Admin
101.77102.5677.8379.979.17
Research & Development
75.275.3571.4758.348.94
Operating Expenses
176.78178.07149.59137.99127.82
Operating Income
66.7389.8489.9539.4835.73
Interest Expense
-7.61-9.13-11-9.19-7.82
Interest & Investment Income
4.578.9910.74.011.36
Currency Exchange Gain (Loss)
-0.6713.324.9529.94-9.45
Other Non Operating Income (Expenses)
3.833.573.144.625.52
EBT Excluding Unusual Items
66.85106.5897.7568.8625.34
Gain (Loss) on Sale of Investments
17.254.638.69-6.14-5.72
Gain (Loss) on Sale of Assets
1.22-0.90.020.060
Other Unusual Items
--0.020.03-
Pretax Income
85.32110.32106.4762.8119.62
Income Tax Expense
15.4817.9821.8915.78-0.94
Earnings From Continuing Operations
69.8492.3484.5847.0320.56
Minority Interest in Earnings
1.351.231.131.472.04
Net Income
71.1993.5785.7148.522.59
Net Income to Common
71.1993.5785.7148.522.59
Net Income Growth
-23.92%9.17%76.73%114.67%-
Shares Outstanding (Basic)
5858585757
Shares Outstanding (Diluted)
5959585857
Shares Change (YoY)
-0.13%1.41%0.77%0.33%0.15%
EPS (Basic)
1.231.621.490.850.39
EPS (Diluted)
1.211.591.480.840.39
EPS Growth
-23.90%7.59%75.34%113.67%-
Free Cash Flow
40.82143.9175.5338.13-60.29
Free Cash Flow Per Share
0.692.453.030.66-1.05
Dividend Per Share
0.7000.3000.619-0.253
Dividend Growth
133.33%-51.57%---
Gross Margin
29.09%30.96%28.91%23.11%22.16%
Operating Margin
7.97%10.38%10.86%5.14%4.84%
Profit Margin
8.50%10.81%10.35%6.32%3.06%
Free Cash Flow Margin
4.88%16.63%21.19%4.97%-8.17%
EBITDA
94.11120.11119.7367.7367.29
EBITDA Margin
11.24%13.88%14.45%8.82%9.12%
D&A For EBITDA
27.3730.2729.7828.2531.57
EBIT
66.7389.8489.9539.4835.73
EBIT Margin
7.97%10.38%10.86%5.14%4.84%
Effective Tax Rate
18.14%16.30%20.56%25.12%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.